Holen Sie sich die Stockscreener-App
0.6231
0.00%
0.00
Schlusskurs vom Vortag:
$0.6231
Offen:
$0.605
24-Stunden-Volumen:
170.27K
Relative Volume:
0.11
Marktkapitalisierung:
$2.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-0.09
EPS:
-6.9236
Netto-Cashflow:
$-10.11M
1W Leistung:
-6.55%
1M Leistung:
-2.43%
6M Leistung:
-73.26%
1J Leistung:
-79.57%
1-Tages-Spanne:
$0.60
$0.623
1-Wochen-Bereich:
$0.587
$0.6731
52-Wochen-Spanne:
$0.55
$4.10
Gt Biopharma Inc Stock (GTBP) Company Profile
Firmenname
Gt Biopharma Inc
Sektor
Branche
Telefon
(800) 304-9888
Adresse
505 MONTGOMERY STREET, SAN FRANCISCO
Vergleichen Sie GTBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.51 | 4.21B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.00 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.915 | 217.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2344 | 502.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.51 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | ROTH MKM | Buy |
| 2021-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-17 | Eingeleitet | ROTH Capital | Buy |
Gt Biopharma Inc Aktie (GTBP) Neueste Nachrichten
Will GT Biopharma Inc. bounce back from current supportWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Combining machine learning predictions for GT Biopharma Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com
Real time breakdown of GT Biopharma Inc. stock performance2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
What institutional flow reveals about GT Biopharma Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Understanding GT Biopharma Inc.’s price movementPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
Short interest data insights for GT Biopharma Inc.2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Evaluating GT Biopharma Inc. with trendline analysisWeekly Gains Summary & Safe Entry Point Identification - newser.com
Will GT Biopharma Inc. stock benefit from automation2025 Big Picture & Short-Term High Return Strategies - newser.com
Will GT Biopharma Inc. (OXIA) stock test record highs in 2025Analyst Downgrade & Risk Managed Investment Signals - newser.com
Is GT Biopharma Inc. stock ready for breakoutJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Using R and stats models for GT Biopharma Inc. forecastingJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
Can GT Biopharma Inc. stock sustain free cash flow growthJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak - MSN
News impact scoring models applied to GT Biopharma Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
EBITDA of GT Biopharma, Inc. – BOATS:GTBP - TradingView
GT Biopharma, Inc. (GTBP) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
GT Biopharma, Inc. (GTBP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Applying chart zones and confluence areas to GT Biopharma Inc.M&A Rumor & AI Driven Price Forecasts - newser.com
Tools to monitor GT Biopharma Inc. recovery probabilityQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Analyzing recovery setups for GT Biopharma Inc. investorsSell Signal & Real-Time Buy Zone Alerts - newser.com
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):